Issues: Vax Specific

Anthrax

Hepatitis B

Hib

HPV

Influenza

Lyme Disease
Meningococcal

MMR    

Polio

Rotavirus

● Smallpox

Tdap/Td

Varicella

Yellow Fever

 

Issues: Misc

Exemptions

Legislation 

New Vax Status

Thimerosal

 

Vaccine Info

2011 Schedule

ACIP Recs

Components
IOM Reports

● Vax Injury Comp Program
Manufacturer Links

Package Inserts

Reporting AEs

Thimerosal Table

VAERS

VISs

 

Links
 

Search
 

About IVS

Faculty Biographies

Publications

Donations

 

Email IVS

 

Disclaimers & Privacy
 

 

Institute for Vaccine Safety

Johns Hopkins Bloomberg School of Public Health

615 N. Wolfe Street

Room W5041

Baltimore, MD 21205

www.vaccinesafety.edu

 

 

 

 

 

Components of
Td Vaccine

Excipients Table
Allergens Table
Components Table

 

Indication

To prevent infection with Clostridium tetani and Corynebacterium diphtheriae

Proprietary Name

DECAVAC

Td (generic)

Manufacturer

sanofi pasteur

sanofi pasteur

Viability

Inactivated

Inactivated

Microorganism

Clostridium tetani and  Corynebacterium diphtheriae

Clostridium tetani and  Corynebacterium diphtheriae

Approved Ages 7 years and older 7 years and older

Dose

0.5 mL

0.5 mL

Route

Intramuscular

Intramuscular

Appearance

Turbid liquid, whitish-gray

Turbid liquid, whitish-gray

Concentration (per 0.5 mL)

Tetanus toxoid, 5 Lf

Diphtheria toxoid, 2 Lf

Tetanus toxoid, 2 Lf

Diphtheria toxoid, 2 Lf

Excipients

Formaldehyde, 100 mcg

Thimerosal, 0.3 mcg mercury (not as a preservative)

Aluminum adjuvant, 0.28 mg Al

Formaldehyde, ≤ 100mcg

Formaldehyde, 100 mcg

Thimerosal, 0.3 mcg mercury (not as a preservative)

Aluminum adjuvant, 0.28 mg Al

Adjuvants

Aluminum adjuvant, 0.28 mg Al

Aluminum adjuvant, ≤ 0.28 mg Al

Allergens

Thimerosal, 0.3 mcg mercury

Tip cap of prefilled syringes may contain natural rubber latex

Thimerosal, ≤0.3 mcg mercury

Preservatives

None

None

Media

Peptone-based

Mueller and Miller (modified)

Peptone-based

Mueller and Miller (modified)

Packaging

Vial, latex free

Syringe, latex free

Vials, single-dose (0.5 mL)

Routine storage

2 to 8° C (36-46° F)

Do Not Freeze

2 to 8° C (36-46° F)

Do Not Freeze

Package Insert updated March 2011 April 2009

updated January 2012

 

This page was last updated on January 23, 2012

© 2012 Institute for Vaccine Safety